Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Keurig Dr Pepper Inc. NASDAQ: KDP. In a filing disclosed on May 31st, the Representative disclosed that they had sold between $1,001 and $15,000 in Keurig Dr Pepper stock on May 15th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Zimmer Biomet NYSE: ZBH on 5/15/2025.
- Sold $15,001 - $50,000 in shares of Elevance Health NYSE: ELV on 5/15/2025.
- Sold $15,001 - $50,000 in shares of PepsiCo NASDAQ: PEP on 5/15/2025.
- Sold $1,001 - $15,000 in shares of WEC Energy Group NYSE: WEC on 5/15/2025.
- Purchased $15,001 - $50,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/15/2025.
- Purchased $1,001 - $15,000 in shares of Hershey NYSE: HSY on 5/15/2025.
- Purchased $1,001 - $15,000 in shares of Kraft Heinz NASDAQ: KHC on 5/15/2025.
- Sold $1,001 - $15,000 in shares of Exxon Mobil NYSE: XOM on 5/15/2025.
- Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 5/15/2025.
- Sold $1,001 - $15,000 in shares of International Flavors & Fragrances NYSE: IFF on 5/15/2025.
Keurig Dr Pepper Trading Down 0.1%
Shares of NASDAQ:KDP traded down $0.02 during trading on Wednesday, reaching $32.80. 11,215,519 shares of the stock were exchanged, compared to its average volume of 10,728,402. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53. Keurig Dr Pepper Inc. has a 12-month low of $30.12 and a 12-month high of $38.28. The firm's 50-day moving average price is $34.13 and its 200 day moving average price is $33.04. The firm has a market cap of $44.55 billion, a price-to-earnings ratio of 19.88, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.04. The business had revenue of $3.64 billion during the quarter, compared to analyst estimates of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The company's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter last year, the firm earned $0.38 earnings per share. On average, sell-side analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date is Friday, June 27th. Keurig Dr Pepper's payout ratio is currently 83.64%.
Hedge Funds Weigh In On Keurig Dr Pepper
Institutional investors have recently modified their holdings of the company. First Hawaiian Bank boosted its stake in Keurig Dr Pepper by 229.6% during the 1st quarter. First Hawaiian Bank now owns 25,673 shares of the company's stock valued at $879,000 after purchasing an additional 17,884 shares during the period. Invst LLC bought a new stake in shares of Keurig Dr Pepper during the first quarter valued at approximately $1,215,000. Strs Ohio acquired a new position in shares of Keurig Dr Pepper during the first quarter worth approximately $10,939,000. Jacobi Capital Management LLC grew its holdings in Keurig Dr Pepper by 15.5% in the 1st quarter. Jacobi Capital Management LLC now owns 15,968 shares of the company's stock worth $546,000 after buying an additional 2,143 shares in the last quarter. Finally, Belpointe Asset Management LLC acquired a new stake in Keurig Dr Pepper in the 1st quarter valued at approximately $614,000. Institutional investors own 93.99% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently commented on KDP shares. Royal Bank of Canada reissued an "outperform" rating and issued a $42.00 price target on shares of Keurig Dr Pepper in a report on Tuesday, April 22nd. Piper Sandler raised Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and upped their target price for the company from $35.00 to $40.00 in a research report on Wednesday, April 9th. UBS Group upped their price target on shares of Keurig Dr Pepper from $40.00 to $42.00 and gave the company a "buy" rating in a report on Thursday, April 17th. Barclays boosted their target price on shares of Keurig Dr Pepper from $37.00 to $38.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Finally, JPMorgan Chase & Co. upped their target price on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. Four analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $39.33.
Check Out Our Latest Stock Report on KDP
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, Director Robert James Gamgort sold 208,000 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $34.12, for a total value of $7,096,960.00. Following the sale, the director now directly owns 2,846,490 shares in the company, valued at approximately $97,122,238.80. The trade was a 6.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $33.39, for a total transaction of $400,680.00. Following the completion of the sale, the insider now directly owns 178,511 shares of the company's stock, valued at $5,960,482.29. The trade was a 6.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 478,500 shares of company stock valued at $16,311,560 in the last quarter. Corporate insiders own 0.40% of the company's stock.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About Keurig Dr Pepper
(
Get Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Recommended Stories
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
